Corporate DisclosureSILVAPHL
SILVAPHL Corporate Disclosure — 10 October 2018
Announcement summary
- What happened
- SILVAPHL published a corporate disclosure on 10 October 2018. Read the full announcement for details.
- Company
- Silva Pharmaceuticals Limited
- Announcement published
Original announcement
(Continuation news of SILVAPHL): On the other hand, NAV per share (considering Pre-IPO paid up shares) was Tk. 17.11 as on 30 June 2018 and the same would be Tk. 15.47 (considering Post-IPO paid up shares). Weighted average Pre-IPO paid-up number of shares was 100,000,000 for the year ended on 30 June 2018 and 77,818,082 for the year ended on 30 June 2017. Post-IPO number of paid-up shares would be 130,000,000. (end)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616aced55a6b00004005bc20
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from SILVAPHL
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.